Brief: Atea Pharmaceuticals Q1 Basic EPS USD -0.4
12/05/2025 21:11
May 12 (Reuters) - Atea Pharmaceuticals Q1 pretax profit USD -34.069 million. Q1 net income USD -34.272 million Q1 operating income USD -39.041 million Q1 operating expenses USD 39.041 million
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM